Evidence map›Paper›PMID 26485430›Full record

ArticleStem cells (Dayton, Ohio)2016

Transforming Growth Factor-β-Induced KDM4B Promotes Chondrogenic Differentiation of Human Mesenchymal Stem Cells.

Hye-Lim Lee, Bo Yu, Peng Deng, Cun-Yu Wang, Christine Hong

Open access · bronzeAbstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. KDM4 Demethylases: Structure, Function, and Inhibitors.Advances in experimental medicine and biology · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. [The Role of Histone Demethylase in Osteogenic and Chondrogenic Differentiation of Mesenchymal Stem Cells: A Literature Review].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Hye-Lim LeeLaboratory of Molecular Signaling, Division of Oral Biology and Medicine, School of Dentistry and Broad Stem Cell Research Center, University of California, Los Angeles, Los Angeles, California, USA.
Bo YuLaboratory of Molecular Signaling, Division of Oral Biology and Medicine, School of Dentistry and Broad Stem Cell Research Center, University of California, Los Angeles, Los Angeles, California, USA.
Peng DengLaboratory of Molecular Signaling, Division of Oral Biology and Medicine, School of Dentistry and Broad Stem Cell Research Center, University of California, Los Angeles, Los Angeles, California, USA.
Cun-Yu WangLaboratory of Molecular Signaling, Division of Oral Biology and Medicine, School of Dentistry and Broad Stem Cell Research Center, University of California, Los Angeles, Los Angeles, California, USA.
Christine HongLaboratory of Molecular Signaling, Division of Oral Biology and Medicine, School of Dentistry and Broad Stem Cell Research Center, University of California, Los Angeles, Los Angeles, California, USA.
University of California, Los Angeles · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARION Xenofon CHATZIIOANNOU · 1985 to 2026
$134.5M
Molecular Regulation of Human Dental Stem Cell PropertyR01DE016513 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WANG, CUN-YU · 2005 to 2019
$6.0M
Molecular Control of MSC differentiation and Bone Formation by KDM4BR01AR063089 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WANG, CUN-YU · 2013 to 2017
$1.6M
Promoting DMSC-mediated craniofacial regeneration by estrogenK08DE024603 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HONG, CHRISTINE · 2014 to 2018
$666k
NCI NIH HHS P30 CA016042NIAMS NIH HHS R01 AR063089NIAMS NIH HHS R01AR063089NIDCR NIH HHS K08 DE024603NIDCR NIH HHS K08DE024603-01NIDCR NIH HHS R01 DE016513NIDCR NIH HHS R01DE16513
6 · The paper itself

Abstract

The high prevalence of cartilage diseases and limited treatment options create a significant biomedical burden. Due to the inability of cartilage to regenerate itself, introducing chondrocyte progenitor cells to the affected site is of significant interest in cartilage regenerative therapies. Tissue engineering approaches using human mesenchymal stem cells (MSCs) are promising due to their chondrogenic potential, but a comprehensive understanding of the mechanisms governing the fate of MSCs is required for precise therapeutic applications in cartilage regeneration. TGF-β is known to induce chondrogenesis by activating SMAD signaling pathway and upregulating chondrogenic genes such as SOX9; however, the epigenetic regulation of TGF-β-mediated chondrogenesis is not understood. In this report, we found that TGF-β dramatically induced the expression of KDM4B in MSCs. When KDM4B was overexpressed, chondrogenic differentiation was significantly enhanced while KDM4B depletion by shRNA led to a significant reduction in chondrogenic potential. Mechanistically, upon TGF-β stimulation, KDM4B was recruited to the SOX9 promoter, removed the silencing H3K9me3 marks, and activated the transcription of SOX9. Furthermore, KDM4B depletion reduced the occupancy of SMAD3 in the SOX9 promoter, suggesting that KDM4B is required for SMAD-dependent coactivation of SOX9. Our results demonstrate the critical role of KDM4B in the epigenetic regulation of TGF-β-mediated chondrogenic differentiation of MSCs. Since histone demethylases are chemically modifiable, KDM4B may be a novel therapeutic target in cartilage regenerative therapy.

Indexed as

Mesenchymal Stem CellsCartilageCell DifferentiationCell LineChondrocytesChondrogenesisEpigenesis, GeneticGene Expression Regulation, DevelopmentalHumansJumonji Domain-Containing Histone DemethylasesOsteogenesisPromoter Regions, GeneticRegenerationSignal TransductionSmad3 ProteinSOX9 Transcription FactorJumonji Domain-Containing Histone DemethylasesKDM4B protein, humanSmad3 ProteinSMAD3 protein, humanSOX9 protein, humanSOX9 Transcription FactorTransforming Growth Factor betaChondrogenesisDifferentiationKDM4BMesenchymal stem cellsSOX9Transforming growth factor-β

Identifiers

PMID26485430
PMCPMC4858413
OpenAlexW2181154597

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.